FDA Approves Dapagliflozin (Farxiga) for Chronic Kidney Disease ...Middle East

Medscape - News
Based on results of the DAPA-CKD trial, the FDA has granted approval for the diabetes drug in patients with CKD at risk for disease progression. FDA Approvals

Hence then, the article about fda approves dapagliflozin farxiga for chronic kidney disease was published today ( ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( FDA Approves Dapagliflozin (Farxiga) for Chronic Kidney Disease )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News